Methods of treating lung cancer
US10016484B2 · kind B2 · utility
0Cited by
30References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2012 |
| Grant date | Jul 10, 2018 |
| Priority date | — |
| Expiry date | May 19, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating cancers comprising FGFR1 gene amplification are provided. In some embodiments, the methods comprise administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule. In some embodiments, the methods comprise administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule in combination with at least one additional therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.